Luke Gilbert
Dr. Luke Gilbert is an Associate Professor at the University of California, San Francisco (UCSF), and a Core Investigator at the Arc Institute of Stanford, UC Berkeley and UCSF. He received his B.S. from UCLA, Ph.D. from MIT and completed his postdoctoral training at UCSF. Dr. Gilbert was an early pioneer in applying CRISPR technology to edit the epigenome, and continues to develop new strategies for editing and understanding human genetics and epigenetics at large scale, with a particular focus on cancer. Dr. Gilbert also co-founded Chroma Medicine in 2020 with the goal of seeing single dose epigenetic editors established as a new type of therapeutic for treatment of human diseases. Dr. Gilbert’s research has been recognized by a NIH Director’s New Innovator Award, a Pew-Stewart scholar for Cancer Research Award, and the AAAS Martin and Rose Wachtel Cancer Research Award.
Information about ticket prices and abstract submissions available at: